Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization admin April 4, 2018 PR You Might Also Like Israel looks to life sciences to safeguard tech edge May 10, 2018 MIXiii-BIOMED 2018: Introducing the Best of Israel’s Life Science Innovations April 3, 2018 Spotlight On Israel: Market Challenges Stunting Biopharma Growth April 24, 2018